These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation. Saleh Y; Abu Hejleh T; Abdelrahim M; Shamseddine A; Chehade L; Alawabdeh T; Mohamad I; Sammour M; Turfa R Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893200 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Therapy With Cabozantinib as a Bridge to Liver Transplantation in Patients With Hepatocellular Carcinoma (HCC): A Case Report. Bhardwaj H; Fritze D; Mais D; Kadaba V; Arora SP Front Transplant; 2022; 1():863086. PubMed ID: 38994388 [TBL] [Abstract][Full Text] [Related]
6. Interventional radiological treatment of hepatocellular carcinoma: an update. Shrimal A; Prasanth M; Kulkarni AV Indian J Surg; 2012 Feb; 74(1):91-9. PubMed ID: 23372313 [TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Liver Transplantation for Hepatocellular Carcinoma. Li PJ; Shah S; Mehta N Curr Treat Options Oncol; 2024 Sep; 25(9):1153-1162. PubMed ID: 39085572 [TBL] [Abstract][Full Text] [Related]
8. Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition? Yin C; Kulasekaran M; Roy T; Decker B; Alexander S; Margolis M; Jha RC; Kupfer GM; He AR Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626165 [TBL] [Abstract][Full Text] [Related]
9. Role of Hepatic Resection for HCC in the era of Transplantation; an Experience of Two Tertiary Egyptian Centers. Senbel A; Elmahdy Y; Roshdy S; Khater A; Shehatoo F; Farouk O; Fathi A; Hamed E; Kotb S; Denwer A Indian J Surg Oncol; 2017 Dec; 8(4):514-518. PubMed ID: 29203983 [TBL] [Abstract][Full Text] [Related]
10. Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC. Kornberg A; Witt U; Matevossian E; Küpper B; Assfalg V; Drzezga A; Hüser N; Wildgruber M; Friess H PLoS One; 2013; 8(1):e53960. PubMed ID: 23349774 [TBL] [Abstract][Full Text] [Related]
11. The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Perumalswami PV; Schiano TD Dig Dis Sci; 2011 May; 56(5):1266-81. PubMed ID: 21416246 [TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization for hepatocellular carcinoma. Van Ha TG Semin Intervent Radiol; 2009 Sep; 26(3):270-5. PubMed ID: 21326572 [No Abstract] [Full Text] [Related]
13. Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. DuBay DA; Sandroussi C; Kachura JR; Ho CS; Beecroft JR; Vollmer CM; Ghanekar A; Guba M; Cattral MS; McGilvray ID; Grant DR; Greig PD HPB (Oxford); 2011 Jan; 13(1):24-32. PubMed ID: 21159100 [TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma. Tanwar S; Khan SA; Grover VP; Gwilt C; Smith B; Brown A World J Gastroenterol; 2009 Nov; 15(44):5511-6. PubMed ID: 19938188 [TBL] [Abstract][Full Text] [Related]
15. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. Huang JH; Gao F; Gu YK; Li WQ; Lu LW World J Gastroenterol; 2007 Dec; 13(48):6593-7. PubMed ID: 18161933 [TBL] [Abstract][Full Text] [Related]
16. Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified? Obed A; Tsui TY; Schnitzbauer AA; Obed M; Schlitt HJ; Becker H; Lorf T Langenbecks Arch Surg; 2008 Mar; 393(2):141-7. PubMed ID: 18043937 [TBL] [Abstract][Full Text] [Related]
17. Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings. Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B World J Gastroenterol; 2007 Dec; 13(45):6022-6. PubMed ID: 18023093 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945 [TBL] [Abstract][Full Text] [Related]